Castrol India Ltd. - Research Center
500870 CASTROLIND Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Dec ' 22 | Dec ' 21 | Dec ' 20 | Dec ' 19 | Dec ' 18 | |
|---|---|---|---|---|---|
| Sales | 4,774.49 | 4,192.10 | 2,996.90 | 3,876.80 | 3,904.60 |
| Operating profit | 1,111.10 | 1,066.00 | 814.10 | 1,153.00 | 1,070.80 |
| Interest | 4.01 | 2.40 | 4.20 | 1.20 | 1.10 |
| Gross profit | 1,174.14 | 1,112.00 | 871.90 | 1,216.60 | 1,154.00 |
| EPS (Rs) | 8.24 | 7.66 | 5.89 | 8.36 | 7.16 |
Annual
results in details
| Dec ' 22 | Dec ' 21 | Dec ' 20 | Dec ' 19 | Dec ' 18 | |
|---|---|---|---|---|---|
| Other income | 67.05 | 48.40 | 62.00 | 64.80 | 84.30 |
| Stock adjustment | -28.35 | -12.10 | -24.10 | 75.70 | -64.60 |
| Raw material | 2,278.87 | 1,879.10 | 1,173.90 | 1,488.30 | 1,757.90 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 272.58 | 232.00 | 219.80 | 213.10 | 203.40 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,140.29 | 1,027.10 | 813.20 | 946.70 | 937.10 |
| Provisions made | - | - | - | - | - |
| Depreciation | 81.39 | 82.70 | 86.60 | 69.70 | 55.60 |
| Taxation | 277.60 | 271.20 | 202.40 | 319.50 | 390.10 |
| Net profit / loss | 815.15 | 758.10 | 582.90 | 827.40 | 708.30 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 494.56 | 494.60 | 494.60 | 494.60 | 494.60 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 23.27 | 25.43 | 27.16 | 29.74 | 27.42 |
| GPM (%) | 24.25 | 26.22 | 28.50 | 30.87 | 28.93 |
| NPM (%) | 16.84 | 17.88 | 19.06 | 20.99 | 17.76 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis